Evidence map›Paper›PMID 25500430›Full record

ArticleGenomics, proteomics & bioinformatics2014

Identification of differentially-expressed genes in intestinal gastric cancer by microarray analysis.

Shizhu Zang, Ruifang Guo, Rui Xing, Liang Zhang, Wenmei Li, Min Zhao, Jingyuan Fang, Fulian Hu, Bin Kang, Yonghong Ren and 7 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Genomics, proteomics & bioinformatics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Artificial intelligence-guided discovery of gastric cancer continuum.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. [Bioinformatics analysis of COL1A1 regulated by miR-129-5p as a potential therapeutic target for gastric cancer].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2019
    Article
  12. Gastric Cancer Cell Lines Have DifferentCanadian journal of gastroenterology & hepatology · 2018
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 2 countries.

Shizhu ZangLaboratory of Molecular Oncology, MOE Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Ruifang GuoLaboratory of Molecular Oncology, MOE Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Rui XingLaboratory of Molecular Oncology, MOE Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Liang ZhangNational Engineering Research Center for Beijing Biochip Technology and Tsinghua University School of Medicine, Beijing 102206, China.
Wenmei LiLaboratory of Molecular Oncology, MOE Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Min ZhaoLaboratory of Molecular Oncology, MOE Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Jingyuan FangDepartment of Gastroenterology, Renji Hospital of Shanghai Second Medical University, Shanghai 200001, China.
Fulian HuDepartment of Gastroenterology, Peking University First Hospital, Beijing 100034, China.
Bin KangLaboratory of Molecular Oncology, MOE Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Yonghong RenNational Engineering Research Center for Beijing Biochip Technology and Tsinghua University School of Medicine, Beijing 102206, China.
Yonglong ZhuangNational Engineering Research Center for Beijing Biochip Technology and Tsinghua University School of Medicine, Beijing 102206, China.
Siqi LiuBeijing Institutes of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
Rong WangDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York 10029, USA.
Xianghong LiDepartment of Pathology, MOE Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Yingyan YuShanghai Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.
Jing ChengNational Engineering Research Center for Beijing Biochip Technology and Tsinghua University School of Medicine, Beijing 102206, China.
Youyong LuLaboratory of Molecular Oncology, MOE Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing 100142, China. Electronic address: youyonglu@bjmu.edu.cn.
Peking University Cancer Hospital · CNTsinghua University · CNPeking University · CNBeijing Institute of Genomics · CNIcahn School of Medicine at Mount Sinai · USPeking University First Hospital · CNRenji Hospital · CNRuijin Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) is one of the most frequent malignant tumors. In order to systematically characterize the cellular and molecular mechanisms of intestinal GC development, in this study, we used 22K oligonucleotide microarrays and bioinformatics analysis to evaluate the gene expression profiles of GC in 45 tissue samples, including 20 intestinal GC tissue samples, 20 normal appearing tissues (NATs) adjacent to tumors and 5 noncancerous gastric mucosa tissue samples. These profiles allowed us to explore the transcriptional characteristics of GC and determine the change patterns in gene expression that may be of clinical significance. 1519 and 1255 differentially-expressed genes (DEGs) were identified in intestinal GC tissues and NATs, respectively, as determined by Bayesian analysis (P<0.001). These genes were associated with diverse functions such as mucosa secretion, metabolism, proliferation, signaling and development, which occur at different stages of GC development.

Indexed as

Gene Expression ProfilingGene Expression Regulation, NeoplasticMicroarray AnalysisBayes TheoremBiomarkers, TumorGastric MucosaHumansIntestinal NeoplasmsStomach NeoplasmsBiomarkers, TumorGastric cancer developmentGene expression profileMicroarray

Identifiers

PMID25500430
PMCPMC4411479
OpenAlexW1998034334

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.